- Home
- KTTA vs ATCH Comparison
KTTA vs ATCH Comparison
Compare KTTA & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- ATCH
- Stock Information
- Founded
- KTTA 2020
- ATCH 2022
- Country
- KTTA United States
- ATCH United States
- Employees
- KTTA N/A
- ATCH N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- KTTA Health Care
- ATCH
- Exchange
- KTTA Nasdaq
- ATCH Nasdaq
- Market Cap
- KTTA 2.8M
- ATCH 3.2M
- IPO Year
- KTTA 2021
- ATCH N/A
- Fundamental
- Price
- KTTA $0.89
- ATCH $0.21
- Analyst Decision
- KTTA
- ATCH
- Analyst Count
- KTTA 0
- ATCH 0
- Target Price
- KTTA N/A
- ATCH N/A
- AVG Volume (30 Days)
- KTTA 2.3M
- ATCH 7.7M
- Earning Date
- KTTA 05-15-2025
- ATCH 05-16-2025
- Dividend Yield
- KTTA N/A
- ATCH N/A
- EPS Growth
- KTTA N/A
- ATCH N/A
- EPS
- KTTA N/A
- ATCH 2.67
- Revenue
- KTTA N/A
- ATCH N/A
- Revenue This Year
- KTTA N/A
- ATCH N/A
- Revenue Next Year
- KTTA N/A
- ATCH N/A
- P/E Ratio
- KTTA N/A
- ATCH $0.08
- Revenue Growth
- KTTA N/A
- ATCH N/A
- 52 Week Low
- KTTA $0.79
- ATCH $0.18
- 52 Week High
- KTTA $7.50
- ATCH $83.99
- Technical
- Relative Strength Index (RSI)
- KTTA 38.94
- ATCH 33.79
- Support Level
- KTTA $0.87
- ATCH $0.19
- Resistance Level
- KTTA $0.95
- ATCH $0.23
- Average True Range (ATR)
- KTTA 0.07
- ATCH 0.02
- MACD
- KTTA 0.01
- ATCH 0.02
- Stochastic Oscillator
- KTTA 40.41
- ATCH 38.18
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.